NATCO Pharma Limited (NATCO) is a vertically integrated, research and development focused pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas.
Financial Results:
- Natco Pharma Ltd. reported Total Income for Q4FY23 of ₹ 2,812 Crores up from ₹ 2,044 Crore year on year, a rise of 38%.
- Total Expenses for Q4FY23 of ₹ 1,950 Crores up from ₹ 1,842 Crores year on year, rise of 6%.
- Consolidated Net Profit of ₹ 715 Crores, up 321% from ₹ 170 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ 39.18, up 320% from ₹ 9.32 in the same quarter of the previous year.